- Filed
- Jul 25, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 22, 2024 | 55.97M sh |
| Shares Diluted | Q2 2024 · Sep 2, 2023 | 55.31M sh |
| Shares Diluted | Q2 2024 · Sep 2, 2023 | 55.24M sh |
| Shares Diluted | Q2 2024 · Aug 27, 2022 | 54.55M sh |
| Shares Diluted | Q2 2024 · Aug 27, 2022 | 54.45M sh |
| Capex | Q2 2024 · Sep 2, 2023 | $76.87M |
| Capex | Q2 2024 · Aug 27, 2022 | $122.24M |
| Operating Cash Flow | Q2 2024 · Sep 2, 2023 | −$813.16M |
| Operating Cash Flow | Q2 2024 · Aug 27, 2022 | −$451.46M |
| Cash And Equivalents | Q2 2024 · Sep 2, 2023 | $92.93M |
| Cash And Equivalents | Q2 2024 · Mar 4, 2023 | $157.15M |
| Stockholders Equity restated | Q2 2024 · Sep 2, 2023 | −$1.91B |
| Stockholders Equity restated | Q2 2024 · Jun 3, 2023 | −$899.6M |
| Stockholders Equity restated | Q2 2024 · Mar 4, 2023 | −$594.23M |
| Stockholders Equity restated | Q2 2024 · Aug 27, 2022 | −$296.28M |
| Stockholders Equity restated | Q2 2024 · May 28, 2022 | $33.17M |
| Stockholders Equity restated | Q2 2024 · Feb 26, 2022 | $115.83M |
| Current Liabilities restated | Q2 2024 · Sep 2, 2023 | $6.5B |
| Current Liabilities restated | Q2 2024 · Mar 4, 2023 | $2.71B |
| Current Liabilities restated | Q2 2024 · Aug 27, 2022 | $2.81B |
| Total Liabilities restated | Q2 2024 · Sep 2, 2023 | $9.03B |
| Total Liabilities restated | Q2 2024 · Mar 4, 2023 | $8.12B |
| Total Liabilities restated | Q2 2024 · Aug 27, 2022 | $8.66B |
| Current Assets | Q2 2024 · Sep 2, 2023 | $3.74B |
| Current Assets | Q2 2024 · Mar 4, 2023 | $3.3B |
| Total Assets | Q2 2024 · Sep 2, 2023 | $7.13B |
| Total Assets | Q2 2024 · Mar 4, 2023 | $7.53B |
| Eps Diluted restated | Q2 2024 · Sep 2, 2023 | −$18.26 |
| Eps Diluted restated | Q2 2024 · Sep 2, 2023 | −$23.83 |
| Eps Diluted restated | Q2 2024 · Aug 27, 2022 | −$6.10 |
| Eps Diluted restated | Q2 2024 · Aug 27, 2022 | −$7.68 |
| Eps Basic restated | Q2 2024 · Sep 2, 2023 | −$18.26 |
| Eps Basic restated | Q2 2024 · Sep 2, 2023 | −$23.83 |
| Eps Basic restated | Q2 2024 · Aug 27, 2022 | −$6.10 |
| Eps Basic restated | Q2 2024 · Aug 27, 2022 | −$7.68 |
| Sga Expense | Q2 2024 · Sep 2, 2023 | $1.46B |
| Sga Expense | Q2 2024 · Sep 2, 2023 | $2.71B |
| Sga Expense | Q2 2024 · Aug 27, 2022 | $1.19B |
| Sga Expense | Q2 2024 · Aug 27, 2022 | $2.41B |
| Net Income restated | Q2 2024 · Sep 2, 2023 | −$1.01B |
| Net Income restated | Q2 2024 · Sep 2, 2023 | −$1.32B |
| Net Income restated | Q2 2024 · Jun 3, 2023 | −$306.41M |
| Net Income restated | Q2 2024 · Aug 27, 2022 | −$332.72M |
| Net Income restated | Q2 2024 · Aug 27, 2022 | −$418.16M |
| Net Income restated | Q2 2024 · May 28, 2022 | −$85.44M |
| Gross Profit | Q2 2024 · Sep 2, 2023 | $1.1B |
| Gross Profit | Q2 2024 · Sep 2, 2023 | $2.27B |
| Gross Profit | Q2 2024 · Aug 27, 2022 | $1.15B |
| Gross Profit | Q2 2024 · Aug 27, 2022 | $2.35B |
| Cost Of Revenue | Q2 2024 · Sep 2, 2023 | $4.55B |
| Cost Of Revenue | Q2 2024 · Sep 2, 2023 | $9.03B |
| Cost Of Revenue | Q2 2024 · Aug 27, 2022 | $4.75B |
| Cost Of Revenue | Q2 2024 · Aug 27, 2022 | $9.56B |
| Long Term Debt | Q2 2024 · Mar 4, 2023 | $2.93B |